Energizing medtech development and taking names: GCMI and T3 Labs CEO Tiffany Wilson named one of Inc.’s “Inspiring Women to Watch in 2017”

GCMI and T3 Labs are proud of our CEO Tiffany Wilson and the commitment and fervor she brings to the medical device community. Recently, Tiffany was recognized as one of Inc.’s “17 inspiring women to watch in 2017.” Each woman spotlighted is an exemplar of leadership and tenacity: acting as a driving force for their…

Igniting medtech innovation: How GCMI assists university-based and physician innovators bring new products to market

  GCMI and T3 Labs CEO Tiffany Wilson shares medtech development pathway insights in Medical Product Outsourcing. Bringing a new medical device from concept to cure to commercialization is an intimidating, complex and expensive process which often stifles innovation instead of encouraging it. Yet there remains a tremendous need and viable markets for medtech innovation…

Influencing future innovators: T3 Labs speaks to the Georgia Tech Masters of Biomedical Innovation and Development class

The Masters of Biomedical Innovation and Development program (BioID program) is a collaborative academic experience in Biomedical technology and a hands-on clinical experience built upon the extraordinary resources and reputation of the Wallace H. Coulter Department of Biomedical Engineering: a joint department of the Georgia Tech College of Engineering and the Emory University School of Medicine.…

Meeting the top needs in preclinical cardiology. Understanding the interaction of next generation bioresorbable platforms with underlying vascular tissue.

How T3 Labs helped Abbott Vascular, Dr. Bill Gogas, Dr. Sandeep Kumar, the core teams of Emory University lead by Dr. Habib Samady, and Georgia Tech lead by Dr. Hanjoong Jo, generate and utilize observations from a very long-term translational study toward the understanding of very late vasomotor responses and gene expression profiles in arteries…

Gearing up to network with cardiothoracic thought leaders in Barcelona at EACTS 2016!

The European Association for Cardio-Thoracic Surgery (EACTS) is holding their annual meeting from October 1-5 in Barcelona, Spain. T3 Labs was originally founded as a cardiovascular research institute, and boasts a decade long track-record in preclinical cardiovascular studies. “The facilities [at T3 Labs] are top tier. They are designed to make it easy to move…

From the back of the napkin through preclinical and commercialization for cardiology interventions

T3 Labs and GCMI always stand ready to help new medical devices and their innovators advance from ‘back of the napkin’ ideas often generated in clinical practice from concept to commercialization and eventually, to cure. Recently T3 Labs’ Deepal Panchal joined Health Connect South Radio Host CW Hall and Dr. Neil Weintraub, MD, Kupperman Eminent…